United States Securities and Exchange Commission · EDGAR Accession 0001640334-25-002246

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 2098209
Raising via Equifund Crowd Funding Portal Inc.

Carnyx Therapeutics, Ltd

CorporationDEIncorporated 2024INDIANAPOLIS, INcarnyxtx.com
A

The Offering

as disclosed in this filing
Common Stock
$1.87
$20,000
$4,999,999
December 3, 2026
172 days remaining
$0max $4,999,999

Target is 0% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 125%0 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(547,219)0
Total assets1,845,1050
Cash & equivalents1,839,5650
Accounts receivable5,5400
Short-term debt138,2340
Long-term debt2,172,5000
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.